SEC Comment Letter 0000000000-24-009638 to TC BioPharm (Holdings) plc (TCBP, TCBPW) (CIK 0001872812) (TCBPY)
TC BioPharm (Holdings) plc (TCBP, TCBPW) (CIK 0001872812)
Date: Aug. 22, 2024 · CIK: 0001872812 · Accession: 0000000000-24-009638
AI Filing Summary & Sentiment
File numbers found in text: 333-281613
Letter
August 22, 2024 Bryan Kobel Chief Executive Officer TC BioPharm (Holdings) plc c/o Business Filings, Inc. 108 West 13th Street Wilmington, Delaware 19801 Re:TC BioPharm (Holdings) plc Registration Statement on Form F-1 Filed August 16, 2024 File No. 333-281613 Dear Bryan Kobel: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tamika Sheppard at 202-551-8346 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Stephen Cohen, Esq.
Show Raw Text
August 22, 2024
Bryan Kobel
Chief Executive Officer
TC BioPharm (Holdings) plc
c/o Business Filings, Inc.
108 West 13th Street
Wilmington, Delaware 19801
Re:TC BioPharm (Holdings) plc
Registration Statement on Form F-1
Filed August 16, 2024
File No. 333-281613
Dear Bryan Kobel:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tamika Sheppard at 202-551-8346 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Stephen Cohen, Esq.